WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 2'6201 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 7'9161 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 44'439  44'658  44'883  45'116  45'349  48'840  51'464  49'969 
Births 473  479  484  489  492  404  645  757 
Surviving infants 470  475  481  485  487  397  634  740 
Pop. less than 5 years 2'334  2'410  2'439  2'483  2'514  2'161  3'458  3'717 
Pop. less than 15 years 6'769  6'725  6'641  6'589  6'562  8'360  10'924  10'745 
Female 15-49 years 10'633  10'785  10'957  11'137  11'321  12'706  12'316  12'737 

Number of reported cases

(Click for retrospective incidence data for Ukraine)
Diphtheria
ChartChart
  365  109 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  102  105  12'746  817  6'841 
Mumps
ChartChart
  439  461  799  26'538 
Pertussis
ChartChart
  3'132  2'426  2'286  2'243  4'189 
Polio*
ChartChart
 
Rubella
ChartChart
  150  248  1'952  37'931 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  23  36 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ukraine)
Vaccine year result method % card seen                                                
BCG 2011  95  MICS   92  75  39  95  99 
DTP1 2011  86  MICS   92  42  59  42 
DTP3 2011  74  MICS   92  19  23  76  99 
DTP4          18  25 
IPV1          75  91 
HepB_BD          37  57  51 
HepB3          26  22  46 
Hib3          47  38  83 
JapEnc         
MCV1          42  56  79  99 
MCV2          31  57  54  99 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2011  73  MICS   92  56  90  45  72  72  99 
Rota1         
RotaC         
RCV1          42  56  79 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ukraine)
BCG
ChartChart
  75  39  39  95  95  98 
DTP1
ChartChart
  42  59  59  76  76  99 
DTP3
ChartChart
  19  23  23  76  76  99 
HepB3
ChartChart
  26  22  22  46  46 
HepB_BD
ChartChart
  37  57  57  51  51 
Hib3
ChartChart
  47  38  38  83  83 
IPV1
  75  59 
MCV1
ChartChart
  42  56  56  79  79  99 
MCV2
ChartChart
  31  57  57  54  54  99 
PCV3
 
Pol3
ChartChart
  56  51  45  72  72  99 
RCV1
ChartChart
  42  56  56  79  79 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 490  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
96 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
95
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 days; 7 years; Yes
DT 6 years; Yes
DTwP 6, 18 months; Yes
DTwPIPV 2, 4 months; Yes
HepB_pediatric birth; 1, 6 months; Yes
HIB 2, 4, 12 months; Yes
Influenza_Adult > 60 years; Yes adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-18 months; 5-14 years; Yes and children with chronic diseases
IPV 2, 4 months; Yes
MMR 12 months; 6 years; Yes
OPV 6, 18 months; 6, 14 years; Yes
Td 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes      Yes  Yes  Yes 
What years does the MYP cover? number   2009-2015      2009-2015  2009-2015  2009-2015 
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 490  486           
Nº districts with DTP3 coverage >=80% number        
% of districts with DTP3 coverage >=80% From 0 to 100%          
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%          

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes        Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes        Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100          100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No        No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.